Table 2.

Characteristics of patients with alcoholic hepatitis (n=89)

Variable
Steroids, n (%), n=87	33 (37.9)
Pentoxifylline, n (%), n=66	6 (9.1)
Antibiotics, n (%), n=87	40 (46.0)
Proton pump inhibitors, n (%), n=44	5 (11.3)
Infections, n (%), n=76	19 (25)
Abstinent at day 30, n=47
Abstinent, n (%)	42 (89.4)
Reduced alcohol consumption, n (%)	3 (6.4)
Continued alcohol abuse, n (%)	2 (4.3)
Stage of Fibrosis, n (%), n=48 0 / 1 / 2 / 3 / 4	2 (4.1) / 0 (0.0) / 6 (12.5) / 5 (10.4) / 35 (72.9)
MELD, median (range), n=87	23.9 (13.2–48.7)
Child-Pugh stage, n (%), n=86 A / B / C	1 (1.2) / 23 (26.7) / 62 (72.1)
30-day survival rate	88.7% (95% CI 81.9–95.9%)
90-day survival rate	80.8% (95% CI 72.5–90.0%)

Antibiotics include prophylactic antibiotics. Values are presented as median (range) for continuous variables or number (percentage) for categorical variables. Percentages are calculated based on the actual number of patients in each group where the respective data was available. The number of subjects for which data were available is indicated in the first column. Survival rates were calculated using Kaplan-Meier curves. Patients were censored at the timepoint they were last seen alive.

MELD, model for end-stage liver disease; CI, confidence interval.